Latest News about BHC
Recent news which mentions BHC
The Smartest Dividend Stocks to Buy With $400 Right Now
April 22, 2022
From Motley Fool
Bausch Health Companies Q4 Sales, FY22 Outlook Lag Wall Street View
February 23, 2022
Tickers
BHC
From Benzinga
The Daily Biotech Pulse: Kodiak Sinks On Adverse Study Outcome, Marinus Flags Delay In Clinical Trial, Mainz Biomed Gains On Positive Regulatory Development
February 23, 2022
From Benzinga
The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow
February 20, 2022
From Benzinga
Why The Justice Department Is Going After Short Sellers
February 17, 2022
From Benzinga
Two Insider Moonshots Rising on Sudden Buying
February 10, 2022
From InvestorPlace
Jim Cramer Buys The Dip In Salesforce, Marvell And This Health Stock
January 21, 2022
From Benzinga
Bausch Health's Eye-Care Spin-Off Entity Files For $100M IPO
January 14, 2022
From Benzinga
The Daily Biotech Pulse: Bausch Files For Eye Health Unit IPO, LumiraDx Antigen Test Can Detect Omicron, Molecular Partners Discloses Fund Stake
January 14, 2022
From Benzinga
Jim Cramer's Top Stocks For 2022: Eli Lilly, Honeywell And More
January 05, 2022
From Benzinga
Stock Market Crash Coming? 7 Wall Street Pros Make Their Predictions
December 29, 2021
From InvestorPlace
BHC Stock: 9 Things to Know as Jim Cramer Buys Bausch Health
December 20, 2021
From InvestorPlace
4 Stocks Insiders Are Buying
December 03, 2021
From Benzinga
Bausch Health Companies inc (BHC) Q3 2021 Earnings Call Transcript
November 02, 2021
Tickers
BHC
From Motley Fool
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
From Benzinga
The Week Ahead In Biotech (Oct. 24-30): Eyenovia, ANI Pharma, Clearside Medical FDA Decisions, Merck, Bristol-Myers Squibb Earnings, IPOs And More
October 24, 2021
From Benzinga
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
From Benzinga
From Benzinga
Why Bausch Health Companies Stock Zoomed 8% Higher Today
September 21, 2021
From Motley Fool
Is Now the Time to Ditch Pharma Stocks?
September 21, 2021
From Motley Fool
Bausch Pays $300M For Diabetes Drug Lawsuit: Reuters
September 10, 2021
From Benzinga
Why Impel NeuroPharma Stock Blasted 27% Higher Thursday
September 09, 2021
From Motley Fool
Why Impel NeuroPharma Stock Is Soaring Today
September 03, 2021
From Motley Fool
From Benzinga